A preclinical study reports that cannabidiol selectively impaired viability, migration, invasion, and clonogenic survival of ...

Cannabidiol has been used for treatment-resistant seizures in patients with severe early-onset epilepsy. We investigated the efficacy and safety of cannabidiol added to a regimen of conventional ...

Among the cannabinoids in cannabis, the main psychoactive compound, THC, often outshines the one that provides a natural anti-anxiety, anti-epileptic and antipsychotic effect. Cannabidiol, or CBD oil, ...

The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug-resistant ...

A new study by researchers at the University of Sydney has shown that taking cannabidiol (CBD) can significantly reduce chronic neuropathic pain in those suffering from it. The findings of the ...

What exactly is cannabidiol (CBD) and more importantly, what does it do? Those questions and more are at the heart of this comprehensive guide to one of the most fascinating and important compounds of ...

Please provide your email address to receive an email when new articles are posted on . Cannabidiol treatment was associated with median reduction of 67% to 99% in focal aware seizures. All ...

Discover comprehensive details about Cannabidiol, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Cannabidiol is effective in treating drug-resistant seizures in Dravet syndrome, according to a new clinical trial. For the first time, a multinational, randomized, double-blind, placebo-controlled ...

Cannabidiol with clobazam is recommended as an option for treating seizures associated with Dravet syndrome in people aged 2 years and older, only if: the frequency of convulsive seizures is checked ...

CHICAGO, June 11, 2025 /PRNewswire/ -- The Global Cannabidiol Market size is projected to be valued at USD 9.14 billion in 2024 and reach USD 22.05 billion by 2030, growing at a CAGR of 15.8% ...